Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 14,172 shares at $8.87 ($126K) on 2025-08-15, disclosed to the SEC on 2025-08-18.
Scheduled sale ($126k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.87 | 7,086 | $63K | 50.0% |
| 2 | $8.87 | 7,086 | $63K | 50.0% |
| Total | $8.87 avg | 14,172 | $126K | 100% |
| Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |
| EBS | SELL | 2024-05-23 | $6K | — | Filing → |